Estimates Revisions Zealand Pharma A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 11:20:00 2025-11-18 EST			5-day change	1st Jan Change
501.20 ^DKK	-4.42%		+15.03%	-29.95%

12:34am	BNP Paribas Exane Lowers Price Target for Zealand Pharma to 840 Danish Kroner (from 905), Reiterates Outperform - BN	FW
11-14	Danske Bank Lowers Price Target for Zealand Pharma to 770 Danish Kroner (from 800), Reiterates Buy - BN	FW

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	ZEALAND PHARMA A/S
	ARGENX SE
	INSMED INCORPORATED
	WUXI APPTEC CO., LTD.
	BIONTECH SE
	GENMAB A/S
	WUXI BIOLOGICS (CAYMAN) INC.
	AKESO, INC.
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
	SUMMIT THERAPEUTICS INC.
	Average
	Weighted average by Cap.